Objective: Infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have a poor prognosis, particularly in immunocompromised patients. While carbapenemase production is the primary resistance mechanism in CRKP, other mechanisms may contribute synergistically to carbapenem resistance. Here, we describe a case in which extended-spectrum β-lactamase (ESBL)-producing K. pneumoniae, initially susceptible to carbapenems, acquired carbapenem resistance without carbapenemase production following ceftolozane-tazobactam exposure.
Methods: Whole-genome sequencing was performed on ESBL-producing K. pneumoniae strains detected during the clinical course to investigate the relationship between the genetic characteristics and antimicrobial susceptibility, particularly to ceftolozane-tazobactam and carbapenems. Changes in the transcription levels of the beta-lactamase genes were also analyzed using reverse transcription quantitative PCR (RT-qPCR).
Results: Active surveillance stool culture before cord blood transplantation (CBT) identified colonization with an ESBL-producing K. pneumoniae strain. Febrile neutropenia occurred on day 7 after CBT and was treated empirically with ceftolozane-tazobactam. Fatal bacteremia developed on day 30 after CBT due to a carbapenemase-negative isolate resistant to both ceftolozane-tazobactam and carbapenems. Whole-genome sequencing analysis revealed that K. pneumoniae ST307 strains harboring blaCTX-M-15, blaSHV-28, and blaTEM-1B acquired a nonsense mutation in ompK36 following ceftolozane-tazobactam exposure. RT-qPCR analysis documented a significant increase in blaSHV-28 transcription after ceftolozane-tazobactam exposure.
Conclusions: This case demonstrates that K. pneumoniae without carbapenemase production can acquire carbapenem resistance through a combined resistance mechanisms following exposure to non-carbapenem antibiotics. Antimicrobial stewardship must be implemented comprehensively, not focused solely on specific antibiotics.
{"title":"Evolution of carbapenem-resistant Klebsiella pneumoniae after ceftolozane-tazobactam exposure in a patient after cord blood transplantation: A case report.","authors":"Shuhei Kurosawa, Sohei Harada, Kohji Komori, Kaworu Takatsuna, Hitomi Ike, Yukihiro Yoshimura, Yuki Iketani, Yoko Tateishi, Hiroyuki Hayashi, Tomonori Nakazato","doi":"10.1016/j.jgar.2026.01.008","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.01.008","url":null,"abstract":"<p><strong>Objective: </strong>Infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have a poor prognosis, particularly in immunocompromised patients. While carbapenemase production is the primary resistance mechanism in CRKP, other mechanisms may contribute synergistically to carbapenem resistance. Here, we describe a case in which extended-spectrum β-lactamase (ESBL)-producing K. pneumoniae, initially susceptible to carbapenems, acquired carbapenem resistance without carbapenemase production following ceftolozane-tazobactam exposure.</p><p><strong>Methods: </strong>Whole-genome sequencing was performed on ESBL-producing K. pneumoniae strains detected during the clinical course to investigate the relationship between the genetic characteristics and antimicrobial susceptibility, particularly to ceftolozane-tazobactam and carbapenems. Changes in the transcription levels of the beta-lactamase genes were also analyzed using reverse transcription quantitative PCR (RT-qPCR).</p><p><strong>Results: </strong>Active surveillance stool culture before cord blood transplantation (CBT) identified colonization with an ESBL-producing K. pneumoniae strain. Febrile neutropenia occurred on day 7 after CBT and was treated empirically with ceftolozane-tazobactam. Fatal bacteremia developed on day 30 after CBT due to a carbapenemase-negative isolate resistant to both ceftolozane-tazobactam and carbapenems. Whole-genome sequencing analysis revealed that K. pneumoniae ST307 strains harboring bla<sub>CTX-M-15</sub>, bla<sub>SHV-28</sub>, and bla<sub>TEM-1B</sub> acquired a nonsense mutation in ompK36 following ceftolozane-tazobactam exposure. RT-qPCR analysis documented a significant increase in bla<sub>SHV-28</sub> transcription after ceftolozane-tazobactam exposure.</p><p><strong>Conclusions: </strong>This case demonstrates that K. pneumoniae without carbapenemase production can acquire carbapenem resistance through a combined resistance mechanisms following exposure to non-carbapenem antibiotics. Antimicrobial stewardship must be implemented comprehensively, not focused solely on specific antibiotics.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146018589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Hospital wastewater serves as a critical source of antimicrobial resistance genes (ARGs), particularly those associated with opportunistic pathogens like Raoultella ornithinolytica. This study aimed to characterize carbapenem-resistant R. ornithinolytica (CR-ROR) isolates carrying the tmexCD2-toprJ2 gene cluster from hospital sewage in Zhejiang province, China.
Methods: Wastewater samples collected from four hospitals in Zhejiang Province were screened for carbapenem-resistant isolates. Whole-genome sequencing using the Illumina platform, combined with bioinformatic analysis, was performed to investigate phylogenetic relationships, associated ARGs, and the structural features of plasmids in tmexCD2-toprJ2-positive CR-ROR isolates.
Results: Five genetically distantly related tmexCD2-toprJ2-positive CR-ROR isolates were identified. All exhibited multidrug-resistant (MDR) phenotypes and carried various ARGs, including carbapenemase genes such as blaKPC-2, blaNDM-1, and blaIMP-4. Genomic analysis revealed that tmexCD2-toprJ2 was plasmid-borne and frequently flanked by mobile genetic elements (MGEs), suggesting a high risk of horizontal gene transfer.
Conclusions: The presence of tmexCD2-toprJ2-carrying CR-ROR in hospital sewage underscores the role of wastewater as a potential environmental reservoir for clinically resistant genes. Ongoing surveillance of hospital effluents is crucial for tracking the dissemination of high-risk antimicrobial resistance determinants and informing timely public health interventions.
{"title":"Characterization of tmexCD2-toprJ2-carrying carbapenem-resistant Raoultella ornithinolytica from hospital sewage in Zhejiang Province of China, 2022-2023.","authors":"Yonglu Huang, Yi Sun, Chang Jiang, Xiangkun Zeng, Yuchen Wu, Zelin Yan, Jing Wang, Hongwei Zhou, Gongxiang Chen, Yongning Wu, Ning Dong","doi":"10.1016/j.jgar.2026.01.002","DOIUrl":"10.1016/j.jgar.2026.01.002","url":null,"abstract":"<p><strong>Objective: </strong>Hospital wastewater serves as a critical source of antimicrobial resistance genes (ARGs), particularly those associated with opportunistic pathogens like Raoultella ornithinolytica. This study aimed to characterize carbapenem-resistant R. ornithinolytica (CR-ROR) isolates carrying the tmexCD2-toprJ2 gene cluster from hospital sewage in Zhejiang province, China.</p><p><strong>Methods: </strong>Wastewater samples collected from four hospitals in Zhejiang Province were screened for carbapenem-resistant isolates. Whole-genome sequencing using the Illumina platform, combined with bioinformatic analysis, was performed to investigate phylogenetic relationships, associated ARGs, and the structural features of plasmids in tmexCD2-toprJ2-positive CR-ROR isolates.</p><p><strong>Results: </strong>Five genetically distantly related tmexCD2-toprJ2-positive CR-ROR isolates were identified. All exhibited multidrug-resistant (MDR) phenotypes and carried various ARGs, including carbapenemase genes such as bla<sub>KPC-2</sub>, bla<sub>NDM-1</sub>, and bla<sub>IMP-4.</sub> Genomic analysis revealed that tmexCD2-toprJ2 was plasmid-borne and frequently flanked by mobile genetic elements (MGEs), suggesting a high risk of horizontal gene transfer.</p><p><strong>Conclusions: </strong>The presence of tmexCD2-toprJ2-carrying CR-ROR in hospital sewage underscores the role of wastewater as a potential environmental reservoir for clinically resistant genes. Ongoing surveillance of hospital effluents is crucial for tracking the dissemination of high-risk antimicrobial resistance determinants and informing timely public health interventions.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":"283-287"},"PeriodicalIF":3.2,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Epidemiological studies on Bacteroides fragilis group (BFG) species and their antimicrobial resistance (AMR) profiles remain scarce worldwide and are lacking in France. The aim of this study was to provide comprehensive national data on the distribution of BFG species, isolation sites, AMR and its potential regional disparity.
Methods: A retrospective multicenter study was conducted from January 2022 to December 2023 using routine data from 45 French hospitals. A total of 9,458 BFG isolates identified to the species level by MALDI-ToF were included. Antimicrobial susceptibility testing (AST) was performed according to French guidelines using either disc diffusion or gradient diffusion methods. AST results were collected for ten antibiotics: amoxicillin-clavulanate (AMC), piperacillin-tazobactam (PIT), imipenem (IMI), clindamycin (CLI), metronidazole (MET), moxifloxacin, tigecycline, linezolid, rifampicin, and chloramphenicol. A Bayesian statistical model was applied to estimate regional resistance frequencies with corresponding credible intervals.
Results: Bacteroides fragilis sensu stricto (B. fragilis) was the most prevalent species (62.4%), followed by Bacteroides thetaiotaomicron (14.2%). Resistance to IMI and MET remained low, while AMC, PIT, and CLI resistance varied markedly across species: 5.2%, 3.6%, and 34.4% for B. fragilis; 18.0%, 50.1%, and 72.9% for B. thetaiotaomicron; and 32.1%, 19.5%, and 75.2% for Parabacteroides distasonis, respectively. Bayesian modelling produced robust regional estimates for B. fragilis, revealing noticeable regional disparities, particularly for AMC, PIT, and MET.
Conclusion: Bayesian modeling revealed substantial interspecies and interregional differences in BFG resistance, highlighting the importance of species-level identification and localized surveillance to inform empirical antibiotic therapy.
{"title":"Antimicrobial resistance in the Bacteroides fragilis group: national multicenter survey and Bayesian modelling study, France, 2022-2023.","authors":"Gauthier Delvallez, Pascal Campagne, Corentine Alauzet, Laure Diancourt, Frédéric Barbut, Hélène Marchandin, Bruno Dupuy","doi":"10.1016/j.jgar.2026.01.003","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.01.003","url":null,"abstract":"<p><strong>Objectives: </strong>Epidemiological studies on Bacteroides fragilis group (BFG) species and their antimicrobial resistance (AMR) profiles remain scarce worldwide and are lacking in France. The aim of this study was to provide comprehensive national data on the distribution of BFG species, isolation sites, AMR and its potential regional disparity.</p><p><strong>Methods: </strong>A retrospective multicenter study was conducted from January 2022 to December 2023 using routine data from 45 French hospitals. A total of 9,458 BFG isolates identified to the species level by MALDI-ToF were included. Antimicrobial susceptibility testing (AST) was performed according to French guidelines using either disc diffusion or gradient diffusion methods. AST results were collected for ten antibiotics: amoxicillin-clavulanate (AMC), piperacillin-tazobactam (PIT), imipenem (IMI), clindamycin (CLI), metronidazole (MET), moxifloxacin, tigecycline, linezolid, rifampicin, and chloramphenicol. A Bayesian statistical model was applied to estimate regional resistance frequencies with corresponding credible intervals.</p><p><strong>Results: </strong>Bacteroides fragilis sensu stricto (B. fragilis) was the most prevalent species (62.4%), followed by Bacteroides thetaiotaomicron (14.2%). Resistance to IMI and MET remained low, while AMC, PIT, and CLI resistance varied markedly across species: 5.2%, 3.6%, and 34.4% for B. fragilis; 18.0%, 50.1%, and 72.9% for B. thetaiotaomicron; and 32.1%, 19.5%, and 75.2% for Parabacteroides distasonis, respectively. Bayesian modelling produced robust regional estimates for B. fragilis, revealing noticeable regional disparities, particularly for AMC, PIT, and MET.</p><p><strong>Conclusion: </strong>Bayesian modeling revealed substantial interspecies and interregional differences in BFG resistance, highlighting the importance of species-level identification and localized surveillance to inform empirical antibiotic therapy.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-08DOI: 10.1016/j.jgar.2025.12.017
Antonio Vitiello, Andrea Zovi, Michela Sabbatucci, Elisa Fabbro, Walter Ricciardi, Leonardo Villani, Giovanni Rezza, Mariarosaria Boccellino, Annalisa Capuano, Francesco Rossi, Marcello Gelormini, Danilo Lo Fo Wong, Francesco Blasi, Cristiana Bellan, Maurizio Acampa, Matteo Bassetti
Objective: Antimicrobial resistance (AMR) poses a significant and growing threat to public health globally, with Italy facing some of the highest resistance rates in Europe. This manuscript reviewed recent Italian intervention studies aimed at mitigating AMR across bacterial, fungal, and viral domains.
Methods: Strategies including antimicrobial stewardship (AMS), infection prevention and control (IPC), antifungal stewardship (AFS), and diagnostic advancements were evaluated. The evidence highlighted both the promise and limitations of Italy's current approach.
Results: While AMS and IPC programs have reduced antibiotic use, healthcare-associated infections, and costs, regional disparities, inconsistent implementation, and limited longitudinal surveillance remain critical challenges. The fungal resistance landscape is marked by rising threats like Candida auris, requiring urgent expansion of AFS programs. Italy's AMR strategy would benefit from improved IPC infrastructure, realtime data integration, and alignment with One Health principles.
Conclusions: Strengthening national coordination, supportinginnovation, and translating surveillance into action at the local level are crucial for turning policy into measurable progress. This review provides actionable insights to guide a more unified and responsive national AMR framework.
{"title":"Intervention studies and antimicrobial resistance in Italy: An overview of the latest evidence.","authors":"Antonio Vitiello, Andrea Zovi, Michela Sabbatucci, Elisa Fabbro, Walter Ricciardi, Leonardo Villani, Giovanni Rezza, Mariarosaria Boccellino, Annalisa Capuano, Francesco Rossi, Marcello Gelormini, Danilo Lo Fo Wong, Francesco Blasi, Cristiana Bellan, Maurizio Acampa, Matteo Bassetti","doi":"10.1016/j.jgar.2025.12.017","DOIUrl":"10.1016/j.jgar.2025.12.017","url":null,"abstract":"<p><strong>Objective: </strong>Antimicrobial resistance (AMR) poses a significant and growing threat to public health globally, with Italy facing some of the highest resistance rates in Europe. This manuscript reviewed recent Italian intervention studies aimed at mitigating AMR across bacterial, fungal, and viral domains.</p><p><strong>Methods: </strong>Strategies including antimicrobial stewardship (AMS), infection prevention and control (IPC), antifungal stewardship (AFS), and diagnostic advancements were evaluated. The evidence highlighted both the promise and limitations of Italy's current approach.</p><p><strong>Results: </strong>While AMS and IPC programs have reduced antibiotic use, healthcare-associated infections, and costs, regional disparities, inconsistent implementation, and limited longitudinal surveillance remain critical challenges. The fungal resistance landscape is marked by rising threats like Candida auris, requiring urgent expansion of AFS programs. Italy's AMR strategy would benefit from improved IPC infrastructure, realtime data integration, and alignment with One Health principles.</p><p><strong>Conclusions: </strong>Strengthening national coordination, supportinginnovation, and translating surveillance into action at the local level are crucial for turning policy into measurable progress. This review provides actionable insights to guide a more unified and responsive national AMR framework.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":"288-296"},"PeriodicalIF":3.2,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-08DOI: 10.1016/j.jgar.2026.01.001
Magdalena Gatsch, Charlotte Aldridge, Kasim Allel, Hassanat Mojirola Lawal, Esmita Charani, Emma Pitchforth
Introduction: Antimicrobial resistance (AMR) is a major global health threat addressed through National Action Plans (NAPs) aligned with the WHO Global Action Plan. Despite evidence that women are disproportionately affected - receiving 27% more antibiotic prescriptions than men - gender considerations remain largely absent from AMR policies.
Methods: We conducted a mixed-methods analysis of 132 NAPs published before December 2023. A two-stage approach was used: quantitative keyword frequency analysis of 10 gender-related terms (e.g., sex, gender, women), followed by a qualitative thematic analysis of top-tier NAPs, defined as those scoring ≥3 gender-related terms on a 10-point frequency scale derived from the former quantitative analysis. We also examined the gender composition of NAP curators and assessed correlations between gender representation and keyword inclusion.
Results: Only 14 NAPs (11%) mentioned the term 'gender'. The most frequent gender-related term was 'urinary tract infection' (UTI), appearing in 33% of NAPs. High-scoring NAPs were predominantly from low-income countries (mean score 2.4, SD = 2.2), especially in Africa (mean 2.5, SD = 2.3), compared to upper-middle-income countries (mean 1.1, SD = 1.07) and the Pan-American region (mean 1.0, SD = 0.9). Women were underrepresented among NAP curators: 47 NAPs were led entirely by men, while only 14 were led by women. No significant correlation was found between women's participation and gender keyword inclusion (β ≈ 0.11, P = 0.449).
Conclusion: Gender remains insufficiently integrated into AMR NAPs. The findings highlight the need for gender awareness policy development and the adoption of an intersectional framework to address overlapping social determinants that shape AMR vulnerability and response.
{"title":"Deconstructing antimicrobial resistance national action plans: A gender-perspective driven mixed-methods analysis.","authors":"Magdalena Gatsch, Charlotte Aldridge, Kasim Allel, Hassanat Mojirola Lawal, Esmita Charani, Emma Pitchforth","doi":"10.1016/j.jgar.2026.01.001","DOIUrl":"10.1016/j.jgar.2026.01.001","url":null,"abstract":"<p><strong>Introduction: </strong>Antimicrobial resistance (AMR) is a major global health threat addressed through National Action Plans (NAPs) aligned with the WHO Global Action Plan. Despite evidence that women are disproportionately affected - receiving 27% more antibiotic prescriptions than men - gender considerations remain largely absent from AMR policies.</p><p><strong>Methods: </strong>We conducted a mixed-methods analysis of 132 NAPs published before December 2023. A two-stage approach was used: quantitative keyword frequency analysis of 10 gender-related terms (e.g., sex, gender, women), followed by a qualitative thematic analysis of top-tier NAPs, defined as those scoring ≥3 gender-related terms on a 10-point frequency scale derived from the former quantitative analysis. We also examined the gender composition of NAP curators and assessed correlations between gender representation and keyword inclusion.</p><p><strong>Results: </strong>Only 14 NAPs (11%) mentioned the term 'gender'. The most frequent gender-related term was 'urinary tract infection' (UTI), appearing in 33% of NAPs. High-scoring NAPs were predominantly from low-income countries (mean score 2.4, SD = 2.2), especially in Africa (mean 2.5, SD = 2.3), compared to upper-middle-income countries (mean 1.1, SD = 1.07) and the Pan-American region (mean 1.0, SD = 0.9). Women were underrepresented among NAP curators: 47 NAPs were led entirely by men, while only 14 were led by women. No significant correlation was found between women's participation and gender keyword inclusion (β ≈ 0.11, P = 0.449).</p><p><strong>Conclusion: </strong>Gender remains insufficiently integrated into AMR NAPs. The findings highlight the need for gender awareness policy development and the adoption of an intersectional framework to address overlapping social determinants that shape AMR vulnerability and response.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":"273-282"},"PeriodicalIF":3.2,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Backgroud: The spread of high-risk XDR Pseudomonas aeruginosa (Pa) clones is a global threat to public health. In Morocco, data on circulating clones, and genomic features of Pa isolates are lacking.
Objectives, materials and methods: Accordingly, this study performed whole-genome sequencing (WGS) (Illumina NextSeq500) of 18 Pa isolates from hospital (n=10) and the community (n=8) to identify their sequence type (ST) affiliation, antimicrobial resistance determinants, virulence factors, and phylogenetic relationships. Isolates were selected based on alarming resistance profiles from strains collected in Casablanca, Morocco between January and December 2021.
Results: These isolates were assigned as sequence type (ST) 773 (n=11), 308 (n=5) and 233 (n=1), in addition to a novel ST4902 for one hospital isolate. Carbapenem-resistance in hospital isolates was primarily attributed to acquired carbapenemases (NDM-1 in ST773 and ST308 clones). In contrast, resistance in one hospital (CSPa93) and one community isolate (cSPa43) was associated with mutations in outer membrane protein. Fluoroquinolone resistance correlated with the carriage of qnrVC1 and crpP genes, along with mutations in the quinolone resistance-determining regions (QRDR). The isolates also carried diverse aminoglycoside modifying enzymes and 16S rRNAmethyltransferase genes. Genomic analysis also identified multiple virulence genes in these isolates, notably exoU in ST308 and ST773 isolates. Phylogenetic analysis further revealed hospital-adapted strains being genetically related to each other and to community strains.
Conclusion: This first genomic investigation of circulating XDR Pa clones in both hospital and community settings in Morocco using WGS highlights the urgent need for enhanced surveillance and targeted strategies to contain the spread of XDR high-risk clones.
{"title":"High-risk Pseudomonas aeruginosa clones ST308, ST773 and ST233 associated with carbapenem-resistant and extensively drug-resistant (XDR) isolates from hospital and community setting in Casablanca, Morocco.","authors":"Ihssane Benzaarate, Fatima El Otmani, Aboubakr Khazaz, Francois Lebreton, Sylvain Brisse, Kaotar Nayme","doi":"10.1016/j.jgar.2025.12.012","DOIUrl":"https://doi.org/10.1016/j.jgar.2025.12.012","url":null,"abstract":"<p><strong>Backgroud: </strong>The spread of high-risk XDR Pseudomonas aeruginosa (Pa) clones is a global threat to public health. In Morocco, data on circulating clones, and genomic features of Pa isolates are lacking.</p><p><strong>Objectives, materials and methods: </strong>Accordingly, this study performed whole-genome sequencing (WGS) (Illumina NextSeq500) of 18 Pa isolates from hospital (n=10) and the community (n=8) to identify their sequence type (ST) affiliation, antimicrobial resistance determinants, virulence factors, and phylogenetic relationships. Isolates were selected based on alarming resistance profiles from strains collected in Casablanca, Morocco between January and December 2021.</p><p><strong>Results: </strong>These isolates were assigned as sequence type (ST) 773 (n=11), 308 (n=5) and 233 (n=1), in addition to a novel ST4902 for one hospital isolate. Carbapenem-resistance in hospital isolates was primarily attributed to acquired carbapenemases (NDM-1 in ST773 and ST308 clones). In contrast, resistance in one hospital (CSPa93) and one community isolate (cSPa43) was associated with mutations in outer membrane protein. Fluoroquinolone resistance correlated with the carriage of qnrVC1 and crpP genes, along with mutations in the quinolone resistance-determining regions (QRDR). The isolates also carried diverse aminoglycoside modifying enzymes and 16S rRNAmethyltransferase genes. Genomic analysis also identified multiple virulence genes in these isolates, notably exoU in ST308 and ST773 isolates. Phylogenetic analysis further revealed hospital-adapted strains being genetically related to each other and to community strains.</p><p><strong>Conclusion: </strong>This first genomic investigation of circulating XDR Pa clones in both hospital and community settings in Morocco using WGS highlights the urgent need for enhanced surveillance and targeted strategies to contain the spread of XDR high-risk clones.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.jgar.2025.11.015
João Pedro Rueda Furlan , Rafael da Silva Rosa , Micaela Santana Ramos , Lucas David Rodrigues dos Santos , Eliana Guedes Stehling
{"title":"Terrestrial plastisphere as a reservoir of high-risk mcr-1-positive Escherichia coli ST744 in a farmhouse","authors":"João Pedro Rueda Furlan , Rafael da Silva Rosa , Micaela Santana Ramos , Lucas David Rodrigues dos Santos , Eliana Guedes Stehling","doi":"10.1016/j.jgar.2025.11.015","DOIUrl":"10.1016/j.jgar.2025.11.015","url":null,"abstract":"","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 146-147"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145677860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to investigate sulbactam-durlobactam (SUL-DUR) susceptibility and molecular features of carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from a Shenzhen teaching hospital.
Methods
A retrospective study on CRAB was conducted from January 2018 to June 2025. Isolates were screened for gyrB and β-lactamase genes (blaOXA-23, −24, −51, and −58). Multi-locus sequence typing (MLST) was used for genotyping, and SUL-DUR susceptibility was tested by disk diffusion. The SUL-DUR-resistant isolate underwent whole-genome sequencing to identify resistance mechanisms.
Results
Of 741 non-duplicate A. baumannii isolates, 147 were CRAB, with its annual percentage rising from 11.4% (2018) to 47.2% (2025). Most isolates came from the ICU (53.7%), and affected patients were predominantly aged ≥60 years (62.6%). Sputum was the primary source (49.7%). Resistance rates exceeded 90% for multiple antibiotics, but only one isolate (0.7%) was resistant to SUL-DUR. This strain harbored nine resistance genes (including blaOXA-23 and blaOXA-66) and had substitutions in penicillin-binding protein 2 (PBP2) and a putative D-Ala-D-Ala carboxypeptidase.
Five sequence types (STs) were identified, including ST2, ST877, ST133, ST195, and a novel sequence type (ST3267), with ST2 being predominant (96.6%). The blaOXA-23 gene was present in 72.8% of isolates, while blaOXA-24 was rare (2.7%). All isolates carried intrinsic blaOXA-51 and gyrB, but blaOXA-58 was absent.
Conclusions
The increasing percentage of carbapenem-resistance among A. baumannii, dominated by ST2 and blaOXA-23-positive strains, highlights an urgent need for stricter infection control. Meanwhile, the notable in vitro susceptibility of CRAB to SUL-DUR offers a promising therapeutic alternative for patients infected with CRAB.
{"title":"The epidemiological and molecular characteristics and sulbactam-durlobactam susceptibility of carbapenem-resistant Acinetobacter baumannii in a Chinese teaching hospital","authors":"Hanlian Huang , Qiaomin Zhang , Shaobo Li , Xiaoyan Dai, Zhongbiao Chen, Guili Zhang, Wen Ma, Hongwei Shen","doi":"10.1016/j.jgar.2025.12.003","DOIUrl":"10.1016/j.jgar.2025.12.003","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to investigate sulbactam-durlobactam (SUL-DUR) susceptibility and molecular features of carbapenem-resistant <em>Acinetobacter baumannii</em> (CRAB) isolates from a Shenzhen teaching hospital.</div></div><div><h3>Methods</h3><div>A retrospective study on CRAB was conducted from January 2018 to June 2025. Isolates were screened for <em>gyrB</em> and β-lactamase genes (<em>bla</em>OXA-23, −24, −51, and −58). Multi-locus sequence typing (MLST) was used for genotyping, and SUL-DUR susceptibility was tested by disk diffusion. The SUL-DUR-resistant isolate underwent whole-genome sequencing to identify resistance mechanisms.</div></div><div><h3>Results</h3><div>Of 741 non-duplicate <em>A. baumannii</em> isolates, 147 were CRAB, with its annual percentage rising from 11.4% (2018) to 47.2% (2025). Most isolates came from the ICU (53.7%), and affected patients were predominantly aged ≥60 years (62.6%). Sputum was the primary source (49.7%). Resistance rates exceeded 90% for multiple antibiotics, but only one isolate (0.7%) was resistant to SUL-DUR. This strain harbored nine resistance genes (including <em>bla</em>OXA-23 and <em>bla</em>OXA-66) and had substitutions in penicillin-binding protein 2 (PBP2) and a putative D-Ala-D-Ala carboxypeptidase.</div><div>Five sequence types (STs) were identified, including ST2, ST877, ST133, ST195, and a novel sequence type (ST3267), with ST2 being predominant (96.6%). The <em>bla</em>OXA-23 gene was present in 72.8% of isolates, while <em>bla</em>OXA-24 was rare (2.7%). All isolates carried intrinsic <em>bla</em>OXA-51 and <em>gyrB</em>, but <em>bla</em>OXA-58 was absent.</div></div><div><h3>Conclusions</h3><div>The increasing percentage of carbapenem-resistance among <em>A. baumannii</em>, dominated by ST2 and <em>bla</em>OXA-23-positive strains, highlights an urgent need for stricter infection control. Meanwhile, the notable <em>in vitro</em> susceptibility of CRAB to SUL-DUR offers a promising therapeutic alternative for patients infected with CRAB.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 137-145"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145742994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.jgar.2025.12.001
Sudha Chandrashekar , Shambhavi Nimisha Prasad , Ramesh Masthi N R , Sheilja Walia , Anushree Trikha , Rajeev Sadanandan
Background
Antimicrobial resistance (AMR) poses a formidable threat to public health in India, requiring a multidimensional response that bridges policy, innovation and intersectoral collaborations. The rapid emergence and spread of multidrug-resistant pathogens driven by the misuse of antimicrobials in human health, animal health, agriculture and environmental settings has rendered many existing therapies obsolete, leaving the population vulnerable to untreatable infections.
Objectives
To examine the multifactorial drivers of AMR in India, review current national and state-level policies and explore the potential role of artificial intelligence (AI) in AMR surveillance, prevention and control.
Methods
This review synthesises evidence from published literature, reports and policy documents. It analyses AMR determinants across human, animal and environmental sectors, evaluates policy frameworks such as India’s National Action Plan and State Action Plans to combat AMR.
Results
Key AMR drivers include antibiotic misuse, inadequate regulation, over-the-counter availability, pharmaceutical and hospital wastewater contamination and gaps in infection prevention. India has come up with national and six state level action plans for AMR containment. The measures include stewardship programs, laboratory network strengthening, spreading awareness and intersectoral coordination. The role of AI in strengthening AMR surveillance and clinical decision-making by integrating complex, high-dimensional data for predictive modelling has been explored.
Conclusion
While India has made significant policy and surveillance advances, enforcement gaps, limited awareness and fragmented data hinder progress. Strengthening governance, expanding One Health surveillance, integrating AI and embedding AMR strategies into universal health coverage are critical to mitigating AMR’s health and economic burden.
{"title":"Antimicrobial resistance in India: Integrating the response into health systems for universal health coverage","authors":"Sudha Chandrashekar , Shambhavi Nimisha Prasad , Ramesh Masthi N R , Sheilja Walia , Anushree Trikha , Rajeev Sadanandan","doi":"10.1016/j.jgar.2025.12.001","DOIUrl":"10.1016/j.jgar.2025.12.001","url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobial resistance (AMR) poses a formidable threat to public health in India, requiring a multidimensional response that bridges policy, innovation and intersectoral collaborations. The rapid emergence and spread of multidrug-resistant pathogens driven by the misuse of antimicrobials in human health, animal health, agriculture and environmental settings has rendered many existing therapies obsolete, leaving the population vulnerable to untreatable infections.</div></div><div><h3>Objectives</h3><div>To examine the multifactorial drivers of AMR in India, review current national and state-level policies and explore the potential role of artificial intelligence (AI) in AMR surveillance, prevention and control.</div></div><div><h3>Methods</h3><div>This review synthesises evidence from published literature, reports and policy documents. It analyses AMR determinants across human, animal and environmental sectors, evaluates policy frameworks such as India’s National Action Plan and State Action Plans to combat AMR.</div></div><div><h3>Results</h3><div>Key AMR drivers include antibiotic misuse, inadequate regulation, over-the-counter availability, pharmaceutical and hospital wastewater contamination and gaps in infection prevention. India has come up with national and six state level action plans for AMR containment. The measures include stewardship programs, laboratory network strengthening, spreading awareness and intersectoral coordination. The role of AI in strengthening AMR surveillance and clinical decision-making by integrating complex, high-dimensional data for predictive modelling has been explored.</div></div><div><h3>Conclusion</h3><div>While India has made significant policy and surveillance advances, enforcement gaps, limited awareness and fragmented data hinder progress. Strengthening governance, expanding One Health surveillance, integrating AI and embedding AMR strategies into universal health coverage are critical to mitigating AMR’s health and economic burden.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 195-202"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145827902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.jgar.2025.12.013
Eriko Hashimoto , Sayaka Yoshida , Taito Kitano
Purpose
Although the non-inferiority of adjunctive linezolid (LZD) was indicated for the treatment of invasive group A streptococcal (iGAS) infection, compared with adjunctive clindamycin (CLDM), additional evaluation of comparative effectiveness by subpopulation may further strengthen the evidence. We compared the efficacy of CLDM and LZD combination therapy for iGAS infection.
Methods
In this retrospective cohort study, data were extracted and analysed using TriNetX, a multicentre database. Data were extracted from 1 January 2015 to 30 April 2025, creating two cohorts (adjunctive CLDM and LZD groups). The primary endpoint was mortality within 90 d from diagnosis, which was compared between groups using propensity score matching. Subgroup analyses were conducted according to age, concomitant intravenous immunoglobulin treatment, and study period.
Results
For analysis, 5841 cases were identified in the CLDM combination group and 1426 in the LZD group. The primary endpoint was observed in 170 (12.0%) cases in the CLDM group and 195 (13.8%) in the LZD group. Odds ratio was 0.854 (95% confidence interval 0.685–1.065, P = 0.161), with odds ratio <1 indicating a CLDM-favourable result.
Conclusions
Clinical efficacy of adjunctive CLDM and LZD was compared in patients with iGAS infection. No significant difference in mortality was observed in the overall population. LZD may be a potential alternative in cases where CLDM use is limited by resistance, intolerance, or contraindications.
{"title":"Clinical outcome comparison between adjunctive clindamycin vs. linezolid for invasive group A streptococcal infection","authors":"Eriko Hashimoto , Sayaka Yoshida , Taito Kitano","doi":"10.1016/j.jgar.2025.12.013","DOIUrl":"10.1016/j.jgar.2025.12.013","url":null,"abstract":"<div><h3>Purpose</h3><div>Although the non-inferiority of adjunctive linezolid (LZD) was indicated for the treatment of invasive group A streptococcal (iGAS) infection, compared with adjunctive clindamycin (CLDM), additional evaluation of comparative effectiveness by subpopulation may further strengthen the evidence. We compared the efficacy of CLDM and LZD combination therapy for iGAS infection.</div></div><div><h3>Methods</h3><div>In this retrospective cohort study, data were extracted and analysed using TriNetX, a multicentre database. Data were extracted from 1 January 2015 to 30 April 2025, creating two cohorts (adjunctive CLDM and LZD groups). The primary endpoint was mortality within 90 d from diagnosis, which was compared between groups using propensity score matching. Subgroup analyses were conducted according to age, concomitant intravenous immunoglobulin treatment, and study period.</div></div><div><h3>Results</h3><div>For analysis, 5841 cases were identified in the CLDM combination group and 1426 in the LZD group. The primary endpoint was observed in 170 (12.0%) cases in the CLDM group and 195 (13.8%) in the LZD group. Odds ratio was 0.854 (95% confidence interval 0.685–1.065, <em>P</em> = 0.161), with odds ratio <1 indicating a CLDM-favourable result.</div></div><div><h3>Conclusions</h3><div>Clinical efficacy of adjunctive CLDM and LZD was compared in patients with iGAS infection. No significant difference in mortality was observed in the overall population. LZD may be a potential alternative in cases where CLDM use is limited by resistance, intolerance, or contraindications.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 241-245"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145827940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}